|
AU1197002A
|
|
Low density microspheres
|
|
EP1046394A2
|
|
Novel compositions useful for delivering compounds into a cell
|
|
AU1428099A
|
|
Low density microspheres
|
|
HK1013625A1
|
|
Liposomes as contrast agents for ultrasonic imaging
|
|
WO9925385A1
|
|
A method of increasing nucleic acid synthesis with ultrasound
|
|
AU9136998A
|
|
Method for hyperthermic potentiation of tissue
|
|
AU8840698A
|
|
Novel therapeutic delivery systems
|
|
WO9851282A1
|
|
Solid porous matrices and methods of making and using the same
|
|
US5977538A
|
|
Optoacoustic imaging system
|
|
WO9850041A1
|
|
Novel prodrugs comprising fluorinated amphiphiles
|
|
AU5627198A
|
|
Methods of preparing gas and gaseous precursor-filled microspheres
|
|
US6123923A
|
|
Optoacoustic contrast agents and methods for their use
|
|
US6231834B1
|
|
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
|
AU5161298A
|
|
Perfluorinated-ether compositions as diagnostic contrast agents
|
|
US6139819A
|
|
Targeted contrast agents for diagnostic and therapeutic use
|
|
US6120751A
|
|
Charged lipids and uses for the same
|
|
AU4235697A
|
|
Improved methods for diagnostic imaging using a contrast agent and a vasodilator
|
|
WO9748337A1
|
|
Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
|
US5948387A
|
|
Contrast media for ultrasonic imaging
|
|
US6090800A
|
|
Lipid soluble steroid prodrugs
|
